CA1032539A - 2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof - Google Patents

2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof

Info

Publication number
CA1032539A
CA1032539A CA219,375A CA219375A CA1032539A CA 1032539 A CA1032539 A CA 1032539A CA 219375 A CA219375 A CA 219375A CA 1032539 A CA1032539 A CA 1032539A
Authority
CA
Canada
Prior art keywords
dialkylaminodihydropyridines
amino
production
methods
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA219,375A
Other languages
English (en)
French (fr)
Inventor
Horst Meyer
Friedrich Bossert
Kurt Stoepel
Wulf Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA1032539A publication Critical patent/CA1032539A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA219,375A 1974-02-09 1975-02-04 2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof Expired CA1032539A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2406198A DE2406198C2 (de) 1974-02-09 1974-02-09 Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Publications (1)

Publication Number Publication Date
CA1032539A true CA1032539A (en) 1978-06-06

Family

ID=5906982

Family Applications (1)

Application Number Title Priority Date Filing Date
CA219,375A Expired CA1032539A (en) 1974-02-09 1975-02-04 2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof

Country Status (20)

Country Link
US (1) US4004014A (zh)
JP (1) JPS5943460B2 (zh)
AT (1) AT342590B (zh)
BE (1) BE825245A (zh)
CA (1) CA1032539A (zh)
CH (2) CH613446A5 (zh)
DD (1) DD117452A5 (zh)
DE (1) DE2406198C2 (zh)
DK (1) DK44075A (zh)
ES (2) ES434546A1 (zh)
FI (1) FI750324A (zh)
FR (1) FR2260345B1 (zh)
GB (1) GB1498495A (zh)
HU (1) HU168482B (zh)
IE (1) IE40589B1 (zh)
IL (1) IL46593A (zh)
LU (1) LU71813A1 (zh)
NL (1) NL7501430A (zh)
SE (1) SE402458B (zh)
ZA (1) ZA75790B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
JPS5232217A (en) * 1975-09-05 1977-03-11 Matsushita Electric Ind Co Ltd Ghost eliminating equipment
CA1050587A (en) * 1975-09-30 1979-03-13 Fmc Corporation Rotating gas diffuser
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPS61108258U (zh) * 1984-12-21 1986-07-09
JPH01181681A (ja) * 1988-01-13 1989-07-19 Komori Printing Mach Co Ltd 印刷機のプラウ折り装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860601A (en) * 1972-03-06 1975-01-14 Horst Meyer 2,6-diamino-1,4-dihydropyridine derivatives
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Also Published As

Publication number Publication date
ATA96975A (de) 1977-08-15
SE7501388L (zh) 1975-08-11
FR2260345B1 (zh) 1980-01-11
DD117452A5 (zh) 1976-01-12
US4004014A (en) 1977-01-18
ES434545A1 (es) 1976-12-16
IL46593A0 (en) 1975-04-25
CH605754A5 (zh) 1978-10-13
IE40589B1 (en) 1979-07-04
ES434546A1 (es) 1977-04-01
SE402458B (sv) 1978-07-03
JPS5943460B2 (ja) 1984-10-22
DE2406198C2 (de) 1983-12-15
GB1498495A (en) 1978-01-18
IL46593A (en) 1977-11-30
NL7501430A (nl) 1975-08-12
FR2260345A1 (zh) 1975-09-05
LU71813A1 (zh) 1975-12-09
DK44075A (zh) 1975-10-06
HU168482B (zh) 1976-05-28
CH613446A5 (zh) 1979-09-28
BE825245A (fr) 1975-08-06
DE2406198A1 (de) 1975-08-14
JPS50108268A (zh) 1975-08-26
ZA75790B (en) 1976-02-25
FI750324A (zh) 1975-08-10
IE40589L (en) 1975-08-09
AT342590B (de) 1978-04-10
AU7786375A (en) 1976-08-05

Similar Documents

Publication Publication Date Title
IL46760A0 (en) Novel 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
IL48248A0 (en) New antibiotics,their production and pharmaceutical compositions containing them
IL47360A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
IL46631A0 (en) New cephalosporins,their preparation and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
CA1032539A (en) 2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof
IL48054A0 (en) New vincanol derivatives,their production and pharmaceutical compositions containing them
IL46448A0 (en) New thioamides,their manufacture and pharmaceutical compositions containing them
PH10450A (en) Alkylphenyl benzopyranopyridines,pharmaceutical compositions and method of use thereof
IL46890A0 (en) New-1-aryl-uracils,their production and pharmaceutical compositions containing them
IL47066A0 (en) Novel diaminopyridine derivatives,their production and pharmaceutical compositions containing them
IL48239A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
PH16403A (en) 1-aryloxy-4-amino-2-butanols,their pharmaceutical compositions and method of use
IL48603A0 (en) Hexahydroindolinol derivatives,their production and pharmaceutical compositions containing them
IL46553A0 (en) Naphthyridene derivatives,their production and pharmaceutical compositions containing them
IL47254A0 (en) New dibenzothiepine derivatives,their manufacture and pharmaceutical compositions containing them
IL47263A (en) 3s-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepine-2-ones, their manufacture and pharmaceutical compositions containinthem
IL46634A0 (en) Novel aryloxyaminobutanol derivatives,their preparation and pharmaceutical compositions containing them
AU485418B2 (en) Derivative of gentamine, process therefor and pharmaceutical compositions thereof
IL46909A0 (en) Tetrahydroisoindoline derivatives,their production and pharmaceutical compositions containing them
AU7878975A (en) Derivative of gentamine, process therefor and pharmaceutical compositions thereof